| 英文名称 |
中文名称 |
CAS |
|
Glucagon-like peptide I(human)
|
|
87805-34-3 |
|
GR 82334
|
|
129623-01-4 |
|
GoSlo-SR-5-69
|
|
1363419-31-1 |
|
H-1152 Glycyl Dihydrochloride
|
|
913844-45-8 |
|
GKA50
|
|
851884-87-2 |
|
GPi 688
|
|
918902-32-6 |
|
Neuropeptide Y Antagonist
|
|
158859-98-4 |
|
Ubiquitin Isopeptidase Inhibitor I, G5
|
|
108477-18-5 |
|
GW 583340 Dihydrochloride
|
|
1173023-85-2 |
|
Galnon
|
|
475115-35-6 |
|
GR 125487 sulfamate
|
|
859502-43-5 |
|
GNTI dihydrochloride
|
|
351183-88-5 |
|
Gue 1654
|
|
397290-30-1 |
|
GR 113808
|
|
144625-51-4 |
|
GLP-2 (HUMAN)
|
|
223460-79-5 |
|
GW-803430
|
|
515141-51-2 |
|
GPBAR-A
|
|
877052-79-4 |
|
GYKI 52466 dihydrochloride
|
|
2319722-40-0 |
|
GR-203040 HCl
|
|
168398-02-5 |
|
GLP-1(7-37)
|
|
106612-94-6 |
|
Galloflavin Potassium salt
|
|
1780260-20-9 |
|
Galiellalactone
|
|
133613-71-5 |
|
GSA 10
|
|
300833-95-8 |
|
GW 1929 hydrochloride
|
|
1217466-21-1 |
|
GIP (1-39)
|
|
725474-97-5 |
|
GSK 2239633A
|
|
1240516-71-5 |
|
Gly-β-MCA
|
|
66225-78-3 |
|
GYKI-47261 dihydrochloride
|
|
1217049-32-5 |
|
GR 64349
|
|
137593-52-3 |
|
Human GLP-1 (7-36)-NH2
|
|
107444-51-9 |
|
G-5555
|
|
1648863-90-4 |
|
GS143
|
|
916232-21-8 |
|
GT 2016
|
|
152241-24-2 |
|
GR 55562 dihydrochloride
|
|
159533-25-2 |
|
GaTx2
|
|
194665-85-5 |
|
GSK1702934A
|
|
924377-85-5 |
|
GR 144053 trihydrochloride
|
|
1215333-48-4 |
|
Guangxitoxin 1E
|
|
1233152-82-3 |
|
GSK-2250665A
|
|
1246030-96-5 |
|
gedunin
|
|
2753-30-2 |
|
GSK2194069
|
|
1332331-08-4 |
|
PAPD5-IN-1
|
|
901230-11-3 |
|
GSK 264220A
|
|
685506-42-7 |
|
GSK-J5 hydrochloride
|
|
1797983-32-4 |
|
Akt Inhibitor XI
|
|
902779-59-3 |
|
Pruvanserin Hydrochloride
|
|
443144-27-2 |
|
3'-Fluorobenzylspiperone Maleate
|
|
1135278-61-3 |
|
FPL 55712
|
|
40785-97-5 |
|
FPL 64176
|
|
120934-96-5 |
|
FIIN-1
|
|
1256152-35-8 |
|
Fostriecin sodium salt from Streptomyces pulveraceus
|
|
87860-39-7 |
|
ELA-14 negative control
|
|
1885873-44-8 |
|
Fenobam
|
|
57653-26-6 |
|
ER 819762
|
|
1155773-15-1 |
|
Eggmanone
|
|
505068-32-6 |
|
GLP-2 (rat)
|
|
195262-56-7 |
|
Travoprost
|
|
54276-17-4 |
|
FTI 277
|
|
1217447-06-7 |
|
FITM
|
|
932737-65-0 |
|
6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol hydrochloride
|
|
181217-39-0 |
|
FFN 102 mesylate
|
|
1883548-92-2 |
|
FK 888
|
|
138449-07-7 |
|
FR 122047 hydrochloride
|
|
130717-51-0 |
|
Flutax-2
|
|
301844-13-3 |
|
FR-171113
|
|
173904-50-2 |
|
FTBMT
|
|
1358575-02-6 |
|
Flutax 1
|
|
191930-58-2 |
|
AHN 1-055 hydrochloride
|
|
202646-03-5 |
|
Eact
|
|
461000-66-8 |
|
ER 50891
|
|
187400-85-7 |
|
Eplivanserin hemifumarate
|
|
130580-02-8 |
|
Deltarasin hydrochloride
|
|
1440898-82-7 |
|
Eticlopride hydrochloride
|
|
97612-24-3 |
|
EC 144
|
|
911397-80-3 |
|
Eeyarestatin I
|
|
412960-54-4 |
|
Etazolate hydrochloride
|
|
35838-58-5 |
|
Ellipticine
|
|
519-23-3 |
|
EMD 386088 hydrochloride
|
|
1171123-46-8 |
|
4-Ethynyl-N-ethyl-1,8-naphthalimide
|
|
912921-26-7 |
|
Edaglitazone
|
|
213411-83-7 |
|
(±)-Epibatidine
|
|
148152-66-3 |
|
exo-IWR 1
|
|
1127442-87-8 |
|
DCG IV
|
|
147782-19-2 |
|
DAPK Substrate Peptide
|
|
386769-53-5 |
|
Exo1
|
|
461681-88-9 |
|
Echistatin
|
|
154303-05-6 |
|
Ex 26
|
|
1233332-37-0 |
|
DS2
|
|
374084-31-8 |
|
p38 MAPK Inhibitor VIII
|
|
321351-00-2 |
|
ELA-32 (human)
|
|
1680205-79-1 |
|
Manning Compound
|
|
73168-24-8 |
|
1-Deazaadenosine
|
|
14432-09-8 |
|
Desmethyl-YM 298198
|
|
1177767-57-5 |
|
DNQX disodium salt
|
|
1312992-24-7 |
|
DMCM hydrochloride
|
|
1215833-62-7 |
|
TrxR inhibitor D9
|
|
1527513-89-8 |
|
Dansylhexyl NECA
|
|
219982-12-4 |
|
5,7-Dichlorokynurenic acid sodium salt
|
|
1184986-70-6 |
|
D-Trp8]-γ-MSH
|
|
321351-81-9 |
|
D-myo-Inositol-1,3,4,5-tetrakisphosphate, octapotassium salt
|
|
145843-69-2 |
